tradingkey.logo
tradingkey.logo
Search

Hims & Hers Health Inc

HIMS
Add to Watchlist
32.950USD
-0.590-1.76%
Close 06/23, 16:00ETQuotes delayed by 15 min
7.60BMarket Cap
LossP/E TTM

Hims & Hers Health Inc

32.950
-0.590-1.76%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-1.76%

5 Days

+4.70%

1 Month

+38.74%

6 Months

-5.32%

Year to Date

+1.48%

1 Year

-21.51%

Key Figures
32.625Open
34.680High
12.55MVolume
LossP/E TTM
45.88P/E Dynamic
--Dividend TTM
5.44%Turnover Ratio
33.540Prev. Close
32.529Low
229.58MTurnover
60.31P/E Static
17.04P/B
0.00%Div Yield TTM
-0.84%ROA
70.43052wk High
0.51Volume Ratio
126.04MNet Profit
230.70MShares
-0.0557EPS TTM
2.38Beta
-2.66%ROE
13.74052wk Low
6.41%Amplitude
69.94%Gross Margin
7.60BMarket Cap
8.81Reward/Risk
4.68%Risk Rate

Key Insights

Hims & Hers Health Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 27 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 27.51.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Hims & Hers Health Inc's Score

Industry at a Glance

Industry Ranking
27 / 76
Overall Ranking
120 / 4577
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Hims & Hers Health Inc Highlights

StrengthsRisks
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 169.22% year-on-year.
Undervalued
The company’s latest PE is -602.26, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 208.41M shares, decreasing 15.42% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.29.

Analyst Rating

Based on 17 analysts
Hold
Current Rating
27.509
Target Price
-17.98%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Hims & Hers Health Inc News

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

TradingKey - Wall Street is navigating a two-day inflation gauntlet. Tuesday's CPI print for April arrived hotter than expected, rattling equity markets from telehealth to nuclear energy. Wednesday morning brings the Producer Price Index (PPI) for April — and if today's Consumer Price Index is any g

TradingKeyWed, May 13
TradingKey - Wall Street is navigating a two-day inflation gauntlet. Tuesday's CPI print for April arrived hotter than expected, rattling equity markets from telehealth to nuclear energy. Wednesday morning brings the Producer Price Index (PPI) for April — and if today's Consumer Price Index is any g

Hims & Hers (HIMS) Q1 2026 Earnings Preview: GLP-1 Pivot, Subscriber Surge & Stock Catalyst Watch

TradingKey - Hims & Hers Health (HIMS) is due to release its Q1 2026 results after the closing bell today. Below, we outline what investors should watch for in today's report.

TradingKeyTue, May 12
TradingKey - Hims & Hers Health (HIMS) is due to release its Q1 2026 results after the closing bell today. Below, we outline what investors should watch for in today's report.

Hims & Hers Soars 64% in Three Days as Novo Nordisk Deal Opens Door to GLP-1 Market

TradingKey - Shares of Hims & Hers Health (HIMS.US) surged nearly 64% cumulatively over the first three trading days of this week, with an intraday rally of over 10% on Wednesday.

TradingKeyThu, Mar 12
TradingKey - Shares of Hims & Hers Health (HIMS.US) surged nearly 64% cumulatively over the first three trading days of this week, with an intraday rally of over 10% on Wednesday.

Investing in Health Stock: Will GLP-1 Pill Copycat Restrictions Derail Hims & Hers? Is HIMS Still a Good Choice in 2026?

Hims & Hers' subscription-based business model, coupled with tailored treatment regimens, allows users to maintain lasting engagement, a critical aspect of the company’s growth narrative and a reason why some see Hims & Hers stock as a play on long-term digital health as opposed to a traditional pha

TradingKeyTue, Feb 10
Hims & Hers' subscription-based business model, coupled with tailored treatment regimens, allows users to maintain lasting engagement, a critical aspect of the company’s growth narrative and a reason why some see Hims & Hers stock as a play on long-term digital health as opposed to a traditional pha

Hims & Hers Health Inc (HIMS): The Opportunity is still Strong and Potent

TradingKey - Despite the whole controversy with NVO, we believe HIMS is able to achieve 6 million subscribers and $6 billion of revenue by 2030, due to the large opportunity of growth for the telehealth industry, early investments in logistics capabilities and ability to upsell their patients.

TradingKeyMon, Sep 1
TradingKey - Despite the whole controversy with NVO, we believe HIMS is able to achieve 6 million subscribers and $6 billion of revenue by 2030, due to the large opportunity of growth for the telehealth industry, early investments in logistics capabilities and ability to upsell their patients.

Hims & Hers: A Game-Changer in Telehealth or Just Another Fad?

Explore the exciting world of Hims & Hers (NYSE: HIMS) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!

OtherFri, Aug 8
Explore the exciting world of Hims & Hers (NYSE: HIMS) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Hims & Hers Health Inc Info

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Ticker SymbolHIMS
CompanyHims & Hers Health Inc
CEODudum (Andrew)
Websitehttps://www.forhims.com/

FAQs

What is the current price of Hims & Hers Health Inc (HIMS)?

The current price of Hims & Hers Health Inc (HIMS) is 32.95.

What is the symbol of Hims & Hers Health Inc?

The ticker symbol of Hims & Hers Health Inc is HIMS.

What is the 52-week high of Hims & Hers Health Inc?

The 52-week high of Hims & Hers Health Inc is 70.43.

What is the 52-week low of Hims & Hers Health Inc?

The 52-week low of Hims & Hers Health Inc is 13.74.

What is the market capitalization of Hims & Hers Health Inc?

The market capitalization of Hims & Hers Health Inc is 7.60B.

Is Hims & Hers Health Inc (HIMS) currently rated as Buy, Hold, or Sell?

According to analysts, Hims & Hers Health Inc (HIMS) has an overall rating of signal_hold, with a price target of 27.51.

What is the Earnings Per Share (EPS TTM) of Hims & Hers Health Inc (HIMS)?

The Earnings Per Share (EPS TTM) of Hims & Hers Health Inc (HIMS) is 0.57.
KeyAI